Cardiology · Aortic Stenosis

Treating Aortic Stenosis: Choosing Between TAVR and Surgery

At a Glance

When aortic stenosis requires valve replacement, TAVR usually offers a quicker recovery because it uses a catheter, while SAVR has more long-term durability data, especially for mechanical valves. Age, health, valve anatomy, bicuspid valve, aortic size, and personal goals help the Heart Team recommend an approach.

When your aortic stenosis reaches the point where the valve must be replaced, you and your Heart Team will decide between two primary treatments. Because this is a mechanical problem, medications cannot “fix” the narrowed valve, though they remain vital for managing your blood pressure, rhythm disorders, and overall heart health until intervention ^[1]^[2].

Today, the choice of treatment is guided by your age, your physical health, your goals, and the specific shape of your heart ^[3].

Two Ways to Replace a Valve

There are two main ways to install a new aortic valve:

Surgical Aortic Valve Replacement (SAVR): A surgeon removes your damaged valve and sews a new one (mechanical or biological) into place through an incision in the chest. This has been the “gold standard” for decades ^[3]^[4].
Transcatheter Aortic Valve Replacement (TAVR): A cardiologist or surgeon uses a thin tube (catheter) to thread a collapsible replacement valve through an artery—usually in the groin—and up into the heart. The new valve is expanded inside your old one, pushing the calcium out of the way ^[5]^[4].

Guidelines by Age and Lifespan

National guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA) use age as a starting point for the conversation, though these are frameworks, not absolute rules ^[3]:

Under Age 65: SAVR is generally favored ^[3]. Because younger patients have a longer life expectancy (often 20+ years), they need a valve with the longest possible track record of durability ^[6]. However, a younger patient with high surgical risk may receive TAVR in selected circumstances.
Age 65 to 80: Both TAVR and SAVR are excellent options ^[5]. The choice depends on your personal preferences, your surgical risk, and whether your anatomy is a good fit for a catheter-based approach ^[7].
Over Age 80: TAVR is typically favored because it is less invasive and allows for a much faster recovery in patients who may be more “frail” or have a shorter life expectancy ^[3].

Comparing the Risks and Benefits

Neither procedure is “risk-free,” but they have different complication profiles. Your Heart Team will help you weigh these approximate trade-offs:

Consideration	TAVR (Transcatheter)	SAVR (Surgical)
Recovery Time	Usually 1–3 days in the hospital; back to activities in a few weeks ^[8].	Usually 4–7 days in the hospital; 4–8 weeks for full recovery ^[8].
Pacemaker Risk	Higher risk of needing a permanent pacemaker due to pressure on the heart’s electrical system ^[9]^[10].	Lower risk of needing a new pacemaker ^[9].
Bleeding/AFib	Lower risk of major bleeding and new-onset atrial fibrillation ^[9]^[10].	Higher risk of bleeding, kidney injury, and temporary heart rhythm issues ^[9].
Valve Leak	Higher risk of paravalvular leak (blood leaking around the outside of the new valve) ^[10]^[11].	Lower risk of leakage because the valve is manually sewn into place ^[11].

The Bicuspid Valve Difference

If you were born with a bicuspid aortic valve (two leaflets instead of three), your treatment plan may look different ^[12].

Surgery is often standard: Because bicuspid valves are often shaped irregularly or have heavy, lopsided calcium, surgery (SAVR) is usually the preferred choice for younger, low-risk patients ^[13]^[14].
Aortic Aneurysm: Many people with bicuspid valves also have an enlarged aorta (the main artery). If surgery is already being performed for the valve, the surgeon may replace the ascending aorta at the same time (often considered when the aorta is >4.5 cm). This is a concomitant repair, and thresholds for isolated aortic surgery depend on many individual factors ^[15].
TAVR for Bicuspid: TAVR may still be an option for older bicuspid patients if their CT scan shows the valve is shaped in a way that can safely hold a transcatheter valve ^[16].

Durability: How Long Will It Last?

One of the most frequent questions is, “How long will this valve last?” For mechanical surgical valves, we have data spanning 20 years or more, though they require lifelong anticoagulation ^[3]. For TAVR, we have strong data out to 10 years showing that for many patients, the valves remain functional and durable ^[17].

However, because TAVR is newer, there is more uncertainty about how these valves perform over 15 or 20 years ^[18]. This is why younger patients (under 65) are often encouraged to choose surgery first—to ensure the most durable first step in what may be a “lifetime” of heart valve management ^[19]^[20].

The Heart Team’s Role

Ultimately, your care should be a “shared decision” ^[7]. Your Heart Team (cardiologists and surgeons) will review your CT scans and echocardiograms to see which procedure offers you the best chance for a long, active life with the lowest risk of complications ^[20].

Common questions in this guide

How are TAVR and SAVR different treatments for aortic stenosis?

TAVR places a collapsible replacement valve through a catheter, usually inserted in an artery in the groin, without opening the chest. SAVR removes the damaged valve and sews in a mechanical or biological valve through chest surgery. Both replace the narrowed valve, but the best option depends on age, health, anatomy, and goals.

Which aortic valve replacement is usually recommended based on age?

Age provides a starting framework: surgery is generally favored under 65, both treatments are reasonable from 65 to 80, and TAVR is often favored over 80. These are not absolute rules; surgical risk, anatomy, expected lifespan, and personal preferences also matter.

What are the main risks to compare between TAVR and SAVR?

TAVR usually has less major bleeding and fewer new atrial fibrillation episodes but a higher chance of needing a permanent pacemaker or having a leak around the valve. SAVR has more bleeding, kidney injury, and temporary rhythm problems but less risk of those TAVR-associated complications. Your Heart Team can estimate your personal risk rather than relying only on average results.

How long do TAVR and surgical valves last?

Mechanical surgical valves have a track record of lasting 20 years or more, but they require lifelong blood-thinning treatment. TAVR valves have strong follow-up data through 10 years for many patients, while their performance over 15 or 20 years is less certain. Your age and the possibility of future valve procedures should be part of the decision.

Can someone with a bicuspid aortic valve have TAVR?

Sometimes. Surgery is often preferred for younger, low-risk people with bicuspid valves because the valve shape and uneven calcium can make catheter placement more challenging, and surgery can also repair an enlarged ascending aorta. Older patients may still be candidates for TAVR when CT imaging shows the anatomy can safely hold the valve.

How does recovery compare after TAVR and SAVR?

After TAVR, the hospital stay is often 1 to 3 days, and many people return to activities within a few weeks. SAVR usually requires 4 to 7 days in the hospital and about 4 to 8 weeks for full recovery. Actual recovery varies with health, complications, and the procedure.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on aortic valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Based on my age and overall health, where do I fall on the ACC/AHA guideline 'age framework' for TAVR versus SAVR?
2.If we choose TAVR, what is my specific risk for needing a permanent pacemaker based on the type of valve you plan to use?
3.Does my CT scan show any features—like a calcified raphe or a large aorta—that would make surgery a safer long-term option than TAVR?
4.If I have a TAVR now at my age, what is the plan if the valve wears out in 10 or 15 years?
5.How much experience does this Heart Team have with my specific valve anatomy, especially if I have a bicuspid valve?

Key takeaways

TAVR places a replacement valve through a catheter and usually has a shorter hospital stay and recovery than SAVR.
Guideline age frameworks generally favor SAVR below 65, consider either option from 65 to 80, and favor TAVR over 80, but anatomy, health, risk, and preferences can change the recommendation.
Compared with SAVR, TAVR has higher risks of a permanent pacemaker and paravalvular leak, while SAVR has more bleeding, kidney injury, and temporary rhythm problems.
Mechanical surgical valves have durability data beyond 20 years but require lifelong anticoagulation, whereas TAVR has strong data through 10 years and less certainty beyond that.
Bicuspid valve anatomy or an enlarged aorta may make SAVR more suitable, although selected older patients may still be candidates for TAVR.

References (20)

1
[Aortic stenosis: An update].
Guedeney P, Collet JP
La Revue de medecine interne 2022; (43(3)):145-151 doi:10.1016/j.revmed.2021.06.003.
PMID: 35181161
2
Wait time impact on prognosis for patients awaiting an aortic valve replacement.
Machado Martins I, Oliveira Ferreira C, Costa Oliveira C, et al.
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2025; (44(10)):595-602 doi:10.1016/j.repc.2024.11.020.
PMID: 40789546
3
International Age and Use Criteria for Transcatheter and Surgical Aortic Valve Replacement.
Sharma R, Srivats S, Ata F, Shuhaiber J
Reviews in cardiovascular medicine 2026; (27(6)):49368 doi:10.31083/RCM49368.
PMID: 42416597
4
What Are SAVR Indications in the TAVI Era?
Davalan W, Ben Ali W, Mrad S, Noly PE
Journal of clinical medicine 2025; (14(7)) doi:10.3390/jcm14072357.
PMID: 40217806
5
Redo-Transcatheter Aortic Valve Replacement: Strategies When the First Transcatheter Aortic Valve Replacement Fails.
Perrin N, Asgar AW
US cardiology 2022; (16()):e07 doi:10.15420/usc.2021.18.
PMID: 39600834
6
Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-risk Patients with Severe Aortic Stenosis.
Nguyen Q, Luc JG, MacGillivray TE, Preventza OA
US cardiology 2022; (16()):e18 doi:10.15420/usc.2022.08.
PMID: 39600837
7
Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
Windecker S, Okuno T, Unbehaun A, et al.
European heart journal 2022; (43(29)):2729-2750 doi:10.1093/eurheartj/ehac105.
PMID: 35466382
8
Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials.
Kazemian S, Fallahtafti P, Sharifi M, et al.
Journal of the American Heart Association 2024; (13(21)):e036179 doi:10.1161/JAHA.124.036179.
PMID: 39424419
9
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Updated Systematic Review and Meta-Analysis.
Lerman TT, Levi A, Talmor-Barkan Y, Kornowski R
Journal of cardiovascular development and disease 2023; (10(4)) doi:10.3390/jcdd10040157.
PMID: 37103036
10
Surgical versus transcatheter treatment of aortic valve stenosis-a meta-analysis of low-risk randomized trials with completed 5-year follow-up.
Doenst T, Gregg AC, Kirov H, et al.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2025; (67(7)) doi:10.1093/ejcts/ezaf215.
PMID: 40580456
11
Transcatheter versus surgical aortic valve replacement for severe aortic stenosis in low-risk adults: a network meta-analysis.
Kizzandy K, Pahu YGP, Ratmandhika SR, et al.
Indian journal of thoracic and cardiovascular surgery 2026; (42(9)):1066-1088 doi:10.1007/s12055-026-02245-1.
PMID: 42558786
12
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summary.
Borger MA, Fedak PWM, Stephens EH, et al.
The Journal of thoracic and cardiovascular surgery 2018; (156(2)):473-480 doi:10.1016/j.jtcvs.2017.10.161.
PMID: 30011756
13
Transcatheter Treatment of Bicuspid Aortic Valve Stenosis: From Observational Studies to Randomized Clinical Trials.
Samim D, Siepe M, Jüni P, et al.
Structural heart : the journal of the Heart Team 2025; (9(12)):100754 doi:10.1016/j.shj.2025.100754.
PMID: 41431655
14
Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
Jahangiri M, Prendergast B
Heart (British Cardiac Society) 2024; (110(22)):1291-1297 doi:10.1136/heartjnl-2024-324054.
PMID: 39117383
15
TAVR in Bicuspid Aortic Valve Disease: A Meta-Analysis of Surgical Comparison and Anatomic Predictors.
Lingamsetty SSP, Thyagaturu H, Jitta SR, et al.
Heart, lung & circulation 2026; (35(4)):503-516 doi:10.1016/j.hlc.2025.11.014.
PMID: 41620298
16
The ABC Bicuspid Sizing Protocol for SAPIEN 3 Balloon-Expandable Valves.
Sheth T, Ismail U, Chavarria J, et al.
Structural heart : the journal of the Heart Team 2025; (9(9)):100487 doi:10.1016/j.shj.2025.100487.
PMID: 40895419
17
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
Thyregod HGH, Jørgensen TH, Ihlemann N, et al.
European heart journal 2024; (45(13)):1116-1124 doi:10.1093/eurheartj/ehae043.
PMID: 38321820
18
Decision-Making Approach to the Treatment of Young and Low-Risk Patients With Aortic Stenosis.
Gupta T, Malaisrie SC, Batchelor W, et al.
JACC. Cardiovascular interventions 2024; (17(21)):2455-2471 doi:10.1016/j.jcin.2024.08.032.
PMID: 39537269
19
Lifetime Management of Transcatheter Aortic Valve Replacement: A Guide to Decision-Making and Future Reinterventions.
Lankaputhra M, Stub D, Batchelor RJ, et al.
Journal of clinical medicine 2026; (15(5)) doi:10.3390/jcm15051917.
PMID: 41827334
20
The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis.
Khan S, Shi W, Kaneko T, Baron SJ
US cardiology 2022; (16()):e19 doi:10.15420/usc.2022.04.
PMID: 39600833

This page is for informational purposes only and does not constitute medical advice. Your cardiologist and Heart Team should interpret your anatomy, surgical risk, and long-term valve options.

Guide Contents